发明名称 Modulation of Pathogenicity
摘要 The present invention relates to the use of compounds of the general Formula (I): wherein in Formula (I), R is H, alkyl, cycloalkyl, aryl or heteroaryl; R1 is H, alkyl, cycloalkyl, aryl or heteroaryl; R2 is H, alkyl, cycloalkyl, aryl or heteroaryl; A1 and A2 each independently represent an optionally substituted C1-C20-alkyl group which may contain one or more group(s) Z, or a monocyclic or polycyclic optionally substituted aromatic or non-aromatic ring system which may contain one or more group(s) X, and in case of a polycyclic ring system, said system contains at least one aromatic ring; Z is selected from the group consisting of S, O, N, NR4, CO, CO2, CS, SO or SO2 X is selected from the group consisting of S, O, N, NR4, SO or SO2;
申请公布号 US2010280036(A1) 申请公布日期 2010.11.04
申请号 US20070005810 申请日期 2007.12.28
申请人 AMMENDOLA ALDO;AULINGER-FUCHS KATHARINA;GOTSCHLICH ASTRID;KRAMER BERND;LANG MARTIN;SAEB WAEL;SINKS UDO;WUZIK ANDREAS 发明人 AMMENDOLA ALDO;AULINGER-FUCHS KATHARINA;GOTSCHLICH ASTRID;KRAMER BERND;LANG MARTIN;SAEB WAEL;SINKS UDO;WUZIK ANDREAS
分类号 A61K31/498;A01N43/54;A01N43/56;A61K8/49;A61K31/175;A61K31/38;A61K31/381;A61K31/415;A61K31/4155;A61K31/42;A61K31/421;A61K31/425;A61K31/426;A61K31/435;A61K31/44;A61K31/4436;A61K31/444;A61K31/445;A61K31/505;A61K31/506;A61P31/04;A61Q17/00;A61Q19/00;C07D231/16;C07D231/40;C07D261/18;C07D263/48;C07D275/03;C07D277/54;C07D307/68;C07D333/38;C07D333/70;C07D401/12;C07D403/12;C07D409/04;C07D409/12;C07D471/04;C12N1/20 主分类号 A61K31/498
代理机构 代理人
主权项
地址